Compare IEX & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IEX | MEDP |
|---|---|---|
| Founded | 1987 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 13.4B |
| IPO Year | 1991 | 2016 |
| Metric | IEX | MEDP |
|---|---|---|
| Price | $177.35 | $547.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 12 |
| Target Price | $198.80 | ★ $465.18 |
| AVG Volume (30 Days) | ★ 606.4K | 277.0K |
| Earning Date | 10-29-2025 | 10-22-2025 |
| Dividend Yield | ★ 1.60% | N/A |
| EPS Growth | N/A | ★ 25.36 |
| EPS | 6.32 | ★ 14.32 |
| Revenue | ★ $3,421,300,000.00 | $2,358,373,000.00 |
| Revenue This Year | $6.31 | $21.48 |
| Revenue Next Year | $2.96 | $11.90 |
| P/E Ratio | ★ $28.09 | $38.28 |
| Revenue Growth | 7.09 | ★ 13.88 |
| 52 Week Low | $153.36 | $250.05 |
| 52 Week High | $231.76 | $626.26 |
| Indicator | IEX | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 66.05 | 36.48 |
| Support Level | $172.38 | $530.96 |
| Resistance Level | $179.59 | $626.26 |
| Average True Range (ATR) | 3.13 | 18.24 |
| MACD | 1.07 | -8.14 |
| Stochastic Oscillator | 88.20 | 17.60 |
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.